Activating Compound | Comment | Organism | Structure |
---|---|---|---|
additional information | clofibrate induces the enzyme | Mus musculus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(1R,2R)-1,2-epoxy-1-phenyl-1-propane | weak inhibition, IC50 is 1.1 mM | Mus musculus | |
(1S,2S)-1,2-epoxy-1-phenyl-1-propane | weak inhibition, IC50 is 2.4 mM, preincubation of enzyme with inhibitor does not influence the inhibitory effect | Mus musculus | |
(2R,3R)-1-acetoxy-2,3-epoxy-3-(4-nitrophenyl)propane | IC50 is 0.069 mM | Mus musculus | |
(2R,3R)-1-benzyloxy-2,3-epoxy-3-(4-nitrophenyl)propane | IC50 is 0.024 mM | Mus musculus | |
(2R,3R)-1-ethoxy-2,3-epoxy-3-(4-nitrophenyl)propane | IC50 is 0.069 mM | Mus musculus | |
(2R,3R)-2,3-epoxy-3-(4-nitrophenyl)glycidol | IC50 is 1.2 mM, the S-enantiomer is a 750fold better inhibitor compared to the R-isomer | Mus musculus | |
(2R,3R)-3-(4-bromophenyl)glycidol | preincubation of enzyme with inhibitor increases the inhibitory effect | Mus musculus | |
(2R,3R)-3-(4-nitrophenyl)glycidol | - |
Mus musculus | |
(2S,3S)-1-acetoxy-2,3-epoxy-3-(4-nitrophenyl)propane | IC50 is 0.012 mM, preincubation of enzyme with inhibitor decreases the inhibitory effect | Mus musculus | |
(2S,3S)-1-benzyloxy-2,3-epoxy-3-(4-nitrophenyl)propane | IC50 is 0.039 mM | Mus musculus | |
(2S,3S)-1-ethoxy-2,3-epoxy-3-(4-nitrophenyl)propane | IC50 is 0.012 mM, preincubation of enzyme with inhibitor decreases the inhibitory effect | Mus musculus | |
(2S,3S)-2,3-epoxy-3-(4-nitrophenyl)glycidol | IC50 is 0.0016 mM, the S-enantiomer is a 750fold better inhibitor compared to the R-isomer | Mus musculus | |
(2S,3S)-3-(4-bromophenyl)glycidol | - |
Mus musculus | |
(2S,3S)-3-(4-nitrophenyl)glycidol | preincubation of enzyme with inhibitor increases the inhibitory effect | Mus musculus | |
4-fluorochalcone oxide | IC50 is 0.026 mM | Mus musculus | |
Chalcone oxide | IC50 is 0.055 mM | Mus musculus | |
additional information | inhibitor synthesis, overview, inhibition mechanisms, overview | Mus musculus | |
racemic 2,3-epoxy-1,3-diphenyl-1-propanol | IC50 is 0.029 mM | Mus musculus | |
racemic 2,3-epoxy-3-(4-fluorophenyl)-1-phenyl-1-propanol | IC50 is 0.032 mM | Mus musculus | |
racemic 2,3-epoxy-3-(4-nitrophenyl)-1-phenyl-1-propanol | IC50 is 0.0017 mM | Mus musculus | |
racemic 3,4-epoxy-4-(4-nitrophenyl)-1-butanol | IC50 is 0.012 mM | Mus musculus | |
racemic 3-(4-nitrophenyl)glycidol | IC50 is 0.005 mM | Mus musculus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytosol | - |
Mus musculus | 5829 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | - |
Swiss Webster mice | - |
Purification (Comment) | Organism |
---|---|
from livers, partially by subcellular fractionation | Mus musculus |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
liver | - |
Mus musculus | - |
Synonyms | Comment | Organism |
---|---|---|
CEH | - |
Mus musculus |
Cytosolic epoxide hydrolase | - |
Mus musculus |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Mus musculus |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
9 | - |
assay at | Mus musculus |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0016 | - |
IC50 is 0.0016 mM, the S-enantiomer is a 750fold better inhibitor compared to the R-isomer | Mus musculus | (2S,3S)-2,3-epoxy-3-(4-nitrophenyl)glycidol | |
0.0017 | - |
IC50 is 0.0017 mM | Mus musculus | racemic 2,3-epoxy-3-(4-nitrophenyl)-1-phenyl-1-propanol | |
0.005 | - |
IC50 is 0.005 mM | Mus musculus | racemic 3-(4-nitrophenyl)glycidol | |
0.012 | - |
IC50 is 0.012 mM | Mus musculus | racemic 3,4-epoxy-4-(4-nitrophenyl)-1-butanol | |
0.012 | - |
IC50 is 0.012 mM, preincubation of enzyme with inhibitor decreases the inhibitory effect | Mus musculus | (2S,3S)-1-acetoxy-2,3-epoxy-3-(4-nitrophenyl)propane | |
0.012 | - |
IC50 is 0.012 mM, preincubation of enzyme with inhibitor decreases the inhibitory effect | Mus musculus | (2S,3S)-1-ethoxy-2,3-epoxy-3-(4-nitrophenyl)propane | |
0.024 | - |
IC50 is 0.024 mM | Mus musculus | (2R,3R)-1-benzyloxy-2,3-epoxy-3-(4-nitrophenyl)propane | |
0.026 | - |
IC50 is 0.026 mM | Mus musculus | 4-fluorochalcone oxide | |
0.029 | - |
IC50 is 0.029 mM | Mus musculus | racemic 2,3-epoxy-1,3-diphenyl-1-propanol | |
0.032 | - |
IC50 is 0.032 mM | Mus musculus | racemic 2,3-epoxy-3-(4-fluorophenyl)-1-phenyl-1-propanol | |
0.039 | - |
IC50 is 0.039 mM | Mus musculus | (2S,3S)-1-benzyloxy-2,3-epoxy-3-(4-nitrophenyl)propane | |
0.055 | - |
IC50 is 0.055 mM | Mus musculus | Chalcone oxide | |
0.069 | - |
IC50 is 0.069 mM | Mus musculus | (2R,3R)-1-acetoxy-2,3-epoxy-3-(4-nitrophenyl)propane | |
0.069 | - |
IC50 is 0.069 mM | Mus musculus | (2R,3R)-1-ethoxy-2,3-epoxy-3-(4-nitrophenyl)propane | |
1.1 | - |
weak inhibition, IC50 is 1.1 mM | Mus musculus | (1R,2R)-1,2-epoxy-1-phenyl-1-propane | |
1.2 | - |
IC50 is 1.2 mM, the S-enantiomer is a 750fold better inhibitor compared to the R-isomer | Mus musculus | (2R,3R)-2,3-epoxy-3-(4-nitrophenyl)glycidol | |
2.4 | - |
weak inhibition, IC50 is 2.4 mM, preincubation of enzyme with inhibitor does not influence the inhibitory effect | Mus musculus | (1S,2S)-1,2-epoxy-1-phenyl-1-propane |